AI is transforming clinical development, but what happens when usage costs spike? Jon Newton explains how to govern it before the bill lands.
- Two Planning Mistakes That Quietly Sink Clinical Programs
- Duplicate Tech, Not Technology, Is Burning Out Trial Sites
- The Real Reason Clinical Trial Systems Don't Talk To Each Other
- The Vendor Questions Most Clinical Tech Buyers Forget To Ask
- AI In Clinical Trials: Stop Hyping It, Start Proving It
- What AI Can't Fix In Decentralized Clinical Trial Data
- Decentralized Trials Promised Less Burden. Did They Deliver?
- Wireless Connectivity Is A Data Integrity Issue, Not IT
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Exploring Integrations In Decentralized Clinical Trials
In this blog, see how each decentralized clinical trial is unique and has its own set of requirements. Based on your trial’s design, consider how to plan for necessary system interactions, leverage the data collected, and select the right partner.
-
Why Scalable EDC Systems Matter In Global Pharmaceutical Trials
Sponsors who treat EDC as core infrastructure—not just software—are best positioned to succeed globally. Explore how EDC platforms keep studies compliant while enabling flexibility.
-
Revolutionizing Pediatric Clinical Trials With ePRO And eConsent
Digital tools like ePRO and eConsent are essential in addressing pediatric trial challenges such as the diverse participant ages and family involvement, which impact retention and data quality.
-
EDC Powers End-To-End Data Management In Pharma-Sponsored Trials
As clinical research moves toward adaptive, decentralized, and data-rich models, EDC remains the backbone that makes innovation operationally feasible.
-
Why Prospective Real-World Studies Hold Promise For Research
Clinical research has always been a cautious and time-consuming affair. Discover how prospective real-world studies are poised to transform the role of RWE in clinical research.
-
Fomenting A Culture Of Analytical Excellence In Clinical Development
Building an "analytics culture" in clinical research requires striking a balance between fast, flexible technologies and the right support for trial teams working to integrate these solutions.
-
Who Decides? Navigating AI Governance in Clinical Research
AI in clinical research poses governance challenges. Clear ownership, consistent policies, and aligned teams help manage risk, ensure compliance, and drive responsible innovation in complex trials.
-
The New Standard In Participant-Centric Trials
Clinical technology must serve both scientific rigor and human experience—and Castor is positioning itself at the forefront of this participant-led future.
-
Running Compliant Studies Without Enterprise EDC Overhead
Low-complexity medical device and IVD studies often fall between enterprise EDC systems and spreadsheets. This webinar shows how a compliant, audit-ready alternative works in practice.
-
How Can Real-World Data Benefit Your Trials?
Clinical trial data is being supplemented with real-world data (RWD) gathered from a variety of sources. Dive deeper into this emerging trend to understand its implications for the future of clinical research.
- The Data Was Already There: RWE's Real Bottleneck Is People
- Two Planning Mistakes That Quietly Sink Clinical Programs
- Duplicate Tech, Not Technology, Is Burning Out Trial Sites
- The Real Reason Clinical Trial Systems Don't Talk To Each Other
- The Vendor Questions Most Clinical Tech Buyers Forget To Ask
RECENT NEWSLETTERS
- 09.05.26 -- Best Of August: AI, FDA RWE, And Trial Data Risks
- 09.03.26 -- AI, APIs, and eConsent Are Exposing Trial Workflow Gaps
- 08.27.26 -- Patient Data Breaks Down When Trial Systems Miss Reality
- 08.20.26 -- Clinical AI Validation, Trial Handoffs, And Smarter Study Builds
- 08.13.26 -- AI Urgency, Site-Sponsor Gaps, And Data That Saves Lives